Evidence Based Practice On Patients With Type 2 Diabetes

Bckground While modern lifestyles and medical care have certainly improved the longevity of humans in the developed world, and contributed to a greater quality of life scenario, those same lifestyles have engendered a number of issues that contribute to disease. Lack of proper diet, fast food, high fat and carbohydrate diets without adequate fruits and vegetables, lack of exercise, smoking and alcohol contribute to an epidemic of obesity which, in turn, contributes to a serious metabolic disorder called Diabetes Mellitus Type 2. While not managed by insulin injections, it is nevertheless quite serious and has a number of progressing symptoms that, if not treated properly, can result in cardiovascular, renal and neurological problems, as well as amputation, ocular issues, and even cognitive dysfunction.

Diabetes Mellitus type 1 or type 2 can have short term and long-term complications, symptoms can appear between days to weeks. Throughout, you will gain more information about diabetes, what organs it can affect, symptoms, complications a diabetes patient with type 1, type 2 and gestational diabetes may come across. There are tests such as glycated hemoglobin (A1C) test, fasting blood sugar test, and oral glucose tolerance test (Mayo Clinic, n.d) that show what type of diabetes you have. There are treatments, such as insulin injections or an insulin pump that can be used to treat diabetes (WebMD, n.d).There are new research studies that can possibly cure diabetes but, are very complex, they are still being developed and trying to find

This essay will focus on type 2 diabetes, which is becoming one of the fast growing chronic health conditions in the United Kingdom (UK). Approximately 700 people are diagnosed with type 2 diabetes each day in the UK (Diabetes Uk, (2014)a). It is costing the NHS about £10billion pounds each year to treat diabetes along with its complication and it is expected to rise in the next couple of years (Diabetes UK, (2014)b).

Your written answers to the questions below are to be available to be sighted by your lecturer (not submitted to the School Office) at the start of the tutorial session. To be recorded as attending the tutorial requires that the lecturer deems that the worksheet has been satisfactorily attempted.

Diabetes is a serious medical condition that can also be a risk factor for the development of many different diseases and conditions including dementia, heart disease, and CVA. Thus, effective management of diabetes is very important. Patient compliance can be difficult to achieve if the person affected with diabetes is not educated about the illness or treatment, has not fully accepted the diagnosis or its severity, will not change habits or believes that the prescribed treatment regime is too difficult or ineffective, has cultural beliefs conflicting with the treatment regime, experiences stressful events, lacks social support, or suffers from psychiatric issues unrelated to diabetes (Gerard, Griffin, & Fitzpatrick, 2010). As one may expect, adequate education programs are essential tools when dealing with diabetics. Solid education will provide the patient with information as well as teaching the necessary skills to manage the disorder. The primary focus of any diabetes education program must be to empower patients as a part of the multidisciplinary team. This team should be focused at integrating diabetes into the lives of the patients and this focus should be based on the decisions made by the patient, otherwise the treatment plan can be looked on as forced (Gerald et al., 2010). Every patient stricken with diabetes has the right to benefit from an education program of this type. First, basic education and facts should be administered directly following the diagnosis of

Diabetes mellitus (DM) is a pandemic that affects millions of people. The growth rate of unrecognized pre-diabetes in America is expected to rise up to 52% by 2020 (Lorenzo, 2013). As the prevalence of diabetes increases, so will the complications and burden of the disease. One of the leading causes for cardiovascular disease, renal failure, nontraumatic lower limb amputations, stroke, and new cases of blindness is DM (Lorenzo, 2013).

Diabetes (DM) is one the many initiatives that Healthy People 2020 have been focusing on to reduce this disease morbidity and mortality rates throughout the communities. In the United States alone, the number of individuals diagnosed with diabetes has increased from 1.5 million in 1958 to 25.8 million in 2011. The Center for Disease and prevention (CDC) also estimates in the year 2011, 79 million people age 20 and over were noted to have pre-diabetes, in which the blood sugar was higher than normal levels, however, have not reached the level for a diagnosis of DM. Eleven percent of those individuals with pre-diabetic readings of raised blood glucose will progress in full blown diabetes a matter of three years. Healthy People 2020 have used evidence –based practices to aid in the prevention and treatment of diabetes. Evidence have shown by simply modifying one’s lifestyle such regular exercising and healthy eating have been recognized to effectively prevent or delay the onset of type 2 diabetes in high-risk persons. Case in point, the Diabetes Prevention Program research trial revealed that the utilization of lifestyle interferences had its utmost impact in elderly adults and was also effective in all racial groups.

Cynthia is a 65 year old African American female diagnosed with type 2 diabetes mellitus, diabetic peripheral neuropathy, hypertension, kidney disease, hyperlipidemia and hypothyroidism. She is on glipizide 5 mg po daily to treat her type 2 diabetes. Cynthia revisited the clinic soon after the initiation of the treatment with symptoms of shakiness, sweating, chills, clamminess, lightheadedness and moderately severe headache. In this case study, Cynthia is exhibiting the symptoms of hypoglycemia as she is on sulfonylurea therapy. Sulfonylureas, such as glipizide commonly used as a second-line of therapy in patients with Type 2 Diabetes Mellitus (T2DM), promote insulin release independent of prevailing glucose value and as a result,

The article that I use as peer reviewed journal is “ Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes”. Type 2 diabetes is considered as the most common disease that affect many people. This is a condition that is associated with a high buildup of sugar in the blood stream. The symptoms are constant hunger, fatigue, lack of energy and frequent urination. At milder levels, the symptoms become severe and lead to the death of an individual. Importantly, it also increases the rate of the cardiovascular disease once an individual has been reported to have such symptoms. The cardiovascular diseases lead to a greater rate of complications in patients with type two diabetes and result in loss of life and also in the United States, it has been rated as one of the leading causes of death. Due to this reason, researchers have focused more on the development of appropriate drugs to improve the treatment of the condition. The article on “semaglutide and cardiovascular outcomes in patients with type 2 diabetes” provides beneficial knowledge to the health-care field.

When you think of diseases, you think of tragic illnesses you can not help. Type 2 diabetes, however, has different circumstances; you inflict this disease upon yourself through lack of proper diet and the results are shocking. You might want to think twice about the health effects that pack of doughnuts has to offer than just all the calories. The effects of being unhealthy go deeper down than just how you look.

This literature review aimed to find out the best quality evidences based practice that evaluate the effectiveness of using angiotensin II type 1 receptor blocker (ARBs) in reducing microalbuminuria level in diabetes mellitus type 2 with normotensive. Four RCTs studies were reviewed in this literature. All the selected RCTs were at a high quality level of methodology according to the appraisal tools of SIGN for RCTs. Adrienne et al (2003) , Raymond et al (2006) and Adrienne et al (2006) were scored 1++, and Adnan et al (2009) was graded by +1.

Aaron is a 25-year-old Caucasian (Hispanic/white) male who is over weight, he was recently diagnosed with type 2 diabetes and has a long history of sever asthma. Aaron is a full time college student majoring in graphic design and works part time at GameStop during the week. He is a very sedentary individual and spends most of his time playing games or watching TV indoors. On occasions he spends time going to hockey games and parties with his friends but does not spend much time doing any physical activities. Aaron has had sever asthma since he was a child and has been taking a variety of medications from and early age. Up till the age of 18 Aaron too anti-inflammatories, albuterol the generic name is albuterol sulphate inhalation solution and some of the Brand names are ProAir HFA, ProAir

The purpose of the paper was looking at the quality of life of diabetic patients. Type two diabetics that have a support system compared to those that don’t have a support system have an improved quality of life after being diagnosed. The level of evidence of this study was a cross sectional study. Researching the article was done by going to the Clarkson College website, then going to the student life tab and choosing library. Clicking on the “C” on the article database and clicking on the CINAHL Complete link. Typed in diabetes mellitus in the first box, then where it has the first and changed selection to not, then in the second box typed out systematic review. Then scrolled down to where

A minority ethnic background with a high prevalence of diabetes (e.g. South or East Asian, Middle Eastern, Afro-Caribbean, Hispanic)

Type 2 diabetes is a very well known disease throughout the US. There are about 27 million people in the US with the disease and 86 million others have prediabetes which means their blood glucose is not right but also not high enough to be diabetes yet. 208,000 people under the age of twenty have been diagnosed with either Type 1 or 2 Diabetes.